Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...
A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...
1don MSN
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection
The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results